Radiotherapy With Pembrolizumab in Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
University of Erlangen-Nürnberg Medical School
University of Erlangen-Nürnberg Medical School
MacroGenics
Flamingo Therapeutics NV
Royal Marsden NHS Foundation Trust
Gilead Sciences
M.D. Anderson Cancer Center
EMD Serono
Sanofi
Yale University
Formation Biologics
Numab Therapeutics AG
Regeneron Pharmaceuticals
Thomas Jefferson University
Wake Forest University Health Sciences
Seagen Inc.
Shattuck Labs, Inc.
M.D. Anderson Cancer Center
University of California, San Francisco
GlaxoSmithKline
Pfizer
University of Arizona
Eisai Inc.
MacroGenics
Ipsen
SecuraBio
University of Nebraska
Genmab
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
SynCore Biotechnology Co., Ltd.
University of Washington
SynCore Biotechnology Co., Ltd.
OncoSec Medical Incorporated
University of California, San Francisco
Celldex Therapeutics
Sensei Biotherapeutics, Inc.
National Cancer Institute (NCI)
Nektar Therapeutics
Calithera Biosciences, Inc
Nektar Therapeutics
M.D. Anderson Cancer Center
University of Virginia
Roswell Park Cancer Institute
Incyte Corporation
Ohio State University Comprehensive Cancer Center
Pfizer
Pfizer
Eli Lilly and Company
Dynavax Technologies Corporation
Incyte Corporation